Value-Based Insurance Design


As the healthcare industry struggles to address rising costs and unaffordable care, attention is turning to value-based benefit design options. Altarum has released its outline for a new value-based insurance design model that it will test at pilot sites across the country.
In testimony before the US House Ways and Means Committee’s Health subcommittee, Mark Fendrick, MD, co-director of the University of Michigan Center for Value-Based Insurance Design, discussed the importance of allowing for flexibility and clinical nuance when it comes to encouraging value in Medicare Advantage plans.
As health reform discussions progress, influential stakeholders have urged policy makers to consider increasing the flexibility of health savings account–eligible high-deductible health plans.
A study on the impact of a value-based pharmacy benefit on medication adherence found that offering free chronic disease medications maintained patients’ levels of adherence even after switching to a health plan with a deductible.
Panel discussion with Gerard F. Anderson, PhD, of Johns Hopkins University; Jenny Bryant of PhRMA; Matt Eyles of AHIP; A. Mark Fendrick, MD, of the University of Michigan Center for Value-Based Insurance Design and co-editor in chief of AJMC; Dan Klein of PAN Foundation; and Grant D. Lawless, RPh, MD, FACP, of University of Southern California. The discussion took place at the Cost-Sharing Roundtable: Sustainable Strategies for Providing Access to Critical Medications. The event was co-hosted by the PAN Foundation and The American Journal of Managed Care®.


April 6th to 11th, 2014
Bedford, MA
July 3rd to 5th, 2014
Orlando, FL
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Neutropenia Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST